https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

IDIVAL joins the European health data exchange network EDHEN

8 de July de 2020

Since April, he participates in the construction of a common clinical data model on COVID-19 for the development of research and analysis projects. IDIVAL has joined the European Health Data & Evidence Network (EDHEN), a public-private partnership aimed at building and harmonizing with partners across Europe a federated large-scale data network, always guaranteeing the confidentiality […]

Read more →

GalNAC-MCJ molecule therapeutic agent in patients with fatty liver

Researchers from the Marqués de Valdecilla University Hospital and the Marqués Valdecilla Research Institute Foundation (IDIVAL) have collaborated in a study studying the GalNAC-MCJ molecule as a promising therapeutic agent for patients with fatty liver and advanced stages of disease. This international project is led by CIC bioGUNE Liver Disease by Dr. Malu Martínez Chantar […]

Read more →

Webinar healthcare industry mobility and economic evaluation

The Group in R + D + i in Health Economics of the University of Cantabria, in collaboration with SODERCAN, organizes the Webinar entitled "SANITARY INDUSTRY, MOBILITY AND ECONOMIC EVALUATION". The webinar will deal with topics of special importance and topicality in the new post-covid era: the Cantabrian Health System, the Health Industry, territorial mobility, […]

Read more →

announces a research manager internship contract

1 de July de 2020

IDIVAL announces a temporary internship contract for the development of activities in the field of research and innovation management in health sciences and technologies. The purpose of this program is to promote professional practice and training of technicians in aspects related to research management and support in the field of research management, by learning aspects […]

Read more →

Light serum neurofilaments

29 de June de 2020

Researchers from the IDIVAL neurodegenerative diseases group and the CSUR group of HUMV hereditary ataxias and paraplegia, led by Dr. Jon Infante, have participated in an international multicenter study designed to identify preclinical and progression biomarkers in the most frequent form of autosomal dominant cerebellar ataxia, SCA3. The identification of accurate, reliable and easily accessible […]

Read more →

IDIVAL reaccredited by the Carlos III Health Institute

IDIVAL obtains the official reaccreditation of the Carlos III Health Institute (ISCIII) as a Health Research Institute. A fundamental certification for the exercise of its competences in such fundamental areas as organ and tissue transplants or new therapies, neuroscience, cancer, infectious diseases and the immune system or diseases related to aging and life habits, in […]

Read more →

Biobanco Valdecilla participates in a digital meeting

22 de June de 2020

The Biodeco Valdecilla participates in the first digital meeting of the NorayBanks Community “Pandemics: challenges and opportunities for biobanks” with Biobanco HCB-IDIBAPS. The situation caused by COVID-19 has forced biobanks and their technology partners to take change measures on a daily basis, to establish new forms of work, applicable to any type of biobank and […]

Read more →

Two IDIVAL projects financed in the Call for Challenges-Collaboration

18 de June de 2020

IDIVAL obtains financing for two of the three projects presented in the Call for Challenges – Collaboration according to the proposal for a provisional resolution to grant aid to the call for early processing of 2019 for R + D + i projects “Challenges – Collaboration” of the Program State Research, Development and Innovation Oriented […]

Read more →

BBVA Foundation Frontiers of Knowledge Awards

11 de June de 2020

The BBVA Foundation Frontiers of Knowledge Awards are developed in collaboration with the Higher Council for Scientific Research (CSIC) and recognize fundamental contributions in a wide range of fields of scientific knowledge, technology, humanities and artistic creation. The disciplines and domains of the Frontiers of Knowledge Awards are as follows: 1. Basic Sciences (Physics, Chemistry, […]

Read more →

Effectiveness efficacy and safety of antipsychotics

The PAFIP group (Initial Psychosis Care Program) that is part of the IDIVAL Psychiatry group has published in the International Journal of Neuropsychopharmacology the article “Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone” in which six of the most widely used antipsychotics […]

Read more →